Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Stenvang

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 25, 2013
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expressionChristina Bjerre, Lena Vinther, Kirstine C Belling, et al.
Molecular Oncology|March 20, 2013
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancerMads H Rasmussen, Niels F Jensen, Line S Tarpgaard, et al.
BMC Genomics|June 10, 2016
The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cellsStine Ninel Hansen, Natasja Spring Ehlers, Shida Zhu, et al.
Molecular & Cellular Proteomics : MCP|January 19, 2011
Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological materialMartin Lundberg, Stine Buch Thorsen, Erika Assarsson, et al.
BMC Cancer|January 24, 2016
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell linesHaatisha Jandu, Kristina Aluzaite, Louise Fogh, et al.
Journal of Proteome Research|August 6, 2013
TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cellsOmid Hekmat, Stephanie Munk, Louise Fogh, et al.
Molecular Oncology|March 12, 2015
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistanceNiels F Jensen, Jan Stenvang, Mette K Beck, et al.
Gut|September 27, 2015
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancerJun Yu, Qiang Feng, Sunny Hei Wong, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 25, 2013
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expressionChristina Bjerre, Lena Vinther, Kirstine C Belling, et al.
Molecular Oncology|March 20, 2013
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancerMads H Rasmussen, Niels F Jensen, Line S Tarpgaard, et al.
BMC Genomics|June 10, 2016
The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cellsStine Ninel Hansen, Natasja Spring Ehlers, Shida Zhu, et al.
Molecular & Cellular Proteomics : MCP|January 19, 2011
Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological materialMartin Lundberg, Stine Buch Thorsen, Erika Assarsson, et al.
BMC Cancer|January 24, 2016
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell linesHaatisha Jandu, Kristina Aluzaite, Louise Fogh, et al.
Journal of Proteome Research|August 6, 2013
TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cellsOmid Hekmat, Stephanie Munk, Louise Fogh, et al.
Molecular Oncology|March 12, 2015
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistanceNiels F Jensen, Jan Stenvang, Mette K Beck, et al.
Gut|September 27, 2015
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancerJun Yu, Qiang Feng, Sunny Hei Wong, et al.
Pageof 8